Clinical Trials Directory

Trials / Completed

CompletedNCT02722967

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study will assess the helpfulness of the integrated call center in optimizing use of the Digital Medicine System in adult subjects with Schizophrenia, Major Depressive Disorder, or Bipolar Disorder taking oral aripiprazole.

Detailed description

The Digital Medicine System includes a drug-device combination of aripiprazole + an ingestible event marker (IEM), a wearable sensor (skin patch), and application software to convey the level of activity and rest, and to mark events through the act of ingestion. Physician and self-report are the most commonly used to assess medication compliance yet studies have consistently found that healthcare providers' subjective judgments of medication compliance are often inaccurate, with a tendency for practitioners to overestimate subject adherence. The sponsor's intent is to develop a system that will benefit future subjects by providing the ability to measure their medication-taking behavior in an objective manner and being able to monitor several physiologic parameters.

Conditions

Interventions

TypeNameDescription
DRUGAripiprazole + IEM (Ingestible Event Marker)Oral aripiprazole (2, 5, 10, 15, 20, or 30 mg) with an ingestible event marker in a single daily dose for duration of the trial.

Timeline

Start date
2016-03-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2016-03-30
Last updated
2018-05-23
Results posted
2018-05-23

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02722967. Inclusion in this directory is not an endorsement.